Stoke Therapeutics (STOK) Stock
Stoke Therapeutics (STOK) closed at $26.41 on Nov 17, 2026; its Tenet Score is 50 of 100 against 340 Healthcare peers.
21 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $26.41
- Nov 17, 2026
- Market cap
- $1.7B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 22.05 – 40.22
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 50/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Stoke Therapeutics Inc scores 50/100. Mixed. Strongest on financial health, quality is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ~ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmen…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Maravai LifeSciences Holdings IncMRVI | 29 | $1.9B |
| Biocryst Pharmaceuticals Inc.BCRX | 72 | $1.9B |
| Eton Pharmaceuticals IncETON | 46 | $1.8B |
| Recursion Pharmaceuticals IncRXRX | 53 | $1.8B |
| Agios Pharmaceuticals IncAGIO | 64 | $1.8B |
| Certara IncCERT | 48 | $1.7B |
| Vir Biotechnology IncVIR | 54 | $1.6B |
| Sarepta Therapeutics IncSRPT | 48 | $1.6B |
| ANI Pharmaceuticals IncANIP | 69 | $1.6B |
| Nurix Therapeutics IncNRIX | 84 | $1.6B |
Common questions
What sector and industry is Stoke Therapeutics in?
Stoke Therapeutics is in the Healthcare sector and the Drugs industry.
What is Stoke Therapeutics' Tenet Score?
Stoke Therapeutics' Tenet Score is 50 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




